NEWS

News

Therapeutic Monoclonal Antibodies for Respiratory Diseases

Current challenges and perspectives - at TOURS (France) on March31th - April 1st 2016.
The first occasion to exchange about this new therapy.


Anticorps thérapeutiques et Maladies Respiratoires : enjeux et perspectives - en représentation à TOURS (France) les 31 mars et 1ier Avril 2016.
Le tout premier lieu d’échanges sur cette nouvelle forme de thérapie.



The first congress about Therapeutic Monoclonal Antibodies in Respiratory Diseases will be held at TOURS, on 31th March & 1st April 2016.
The Scientific Committee proposed an exciting and unique scientific program dealing with the variety of monoclonal antibodies, either already on the market or currently in development in respiratory diseases.

Download the scientific program (PDF format) :
PDF - 613.9 kb
TMARD - Scientific program
Scientific program in English

Partnerships:
- The research Center of Respiratory Diseases (CEPR- UMR INSERM 1100)
- The Laboratory of Excellence (LabEx) “MAbImprove”
- The GDR 3260 “Antibodies and therapeutic targeting”, the Grant Research program ARD2020 “Biotherapeutics” (Région Centre-Val-de-Loire)

Aerodrug, Faculté de Médecine, Bâtiment M, 10 ter boulevard Tonnellé, 37032 TOURS France.